About Contact Us Careers

Leucovorin Calcium Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4020
Published Date: Jul 25, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Leucovorin Calcium Landscape

Exelixis Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
PromoCell GmbH
Thermo Fisher Scientific Inc.
Boehringer Ingelheim GmbH
Bayer AG
Abbott Laboratories
Merck & Co., Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc.

Browse Key Market Insights with Data Illustration:

Leucovorin Calcium Market Size, Growth Forecasts 2036

In the News

Exelixis Inc. announced the successful results for Cabozantinib in combination with immunotherapies in patients with advanced colorectal cancer.
PromoCell GmbH to lead research on immunotherapies through all human primary cells and blood & stem cells, including MHC class I genes HLA-A, -B, and -C.

Author Credits: Radhika Pawar

Report ID: 4020
Published Date: Jul 25, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of leucovorin calcium is assessed at USD 26.63 Million.

The leucovorin calcium market size was valued at USD 23.24 Million in 2023 and is likely to reach USD 163.65 Million by the end of 2036, registering around 16.2% CAGR during the forecast period i.e., between 2024-2036. The increasing prevalence of colorectal cancer and rising cancer awareness are some of the major factors anticipated to drive the market growth.

North America industry is expected to have the highest growth through 2036, owing to presence of major pharmaceutical companies in the region.

Exelixis Inc., PromoCell GmbH, Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc.

Inquiry Before Buying Request Free Sample